Navigation Links
GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
Date:8/11/2008

er 50 years of age, women who will be pregnant during the flu season and anyone with chronic health conditions, such as heart disease, asthma, chronic obstructive pulmonary disease (COPD) and diabetes. The CDC also recommends annual vaccination for caregivers and household contacts of these high-risk groups, such as relatives and healthcare workers. In fact, approximately 83 percent of the U.S. population is included in one or more of the target groups that the CDC recommends to receive the vaccination; however, less than 40 percent of the U.S. population received a flu vaccination during 2007-2008.

The beginning, severity and length of the flu season can vary widely from year to year. According to CDC data, the peak in flu activity between the years 1976 and 2008 frequently occurs after December, most commonly in February. In general, healthcare providers should begin offering vaccination soon after the vaccine becomes available and if possible by October. The CDC recommends an extended vaccination effort, with vaccination offered at every opportunity throughout the flu season.

About FLUARIX and FLULAVAL

FLUARIX and FLULAVAL are indicated for active immunization of adults (18 years of age and older) against influenza disease caused by influenza virus subtypes A and type B contained in the vaccines. These indications are based on immune response, and there have been no controlled trials demonstrating a decrease in influenza disease after vaccination with these products. FLUARIX and FLULAVAL are not indicated for use in children.

Important Safety Information

FLUARIX and FLULAVAL should not be administered to anyone with known systemic hypersensitivity reactions to eggs, egg products, egg or chicken proteins, or any component of the vaccines. FLUARIX and FLULAVAL should not be administered to anyone who has had a life-threatening reaction to previous administration of any influenza vaccine. Immunization should be delayed in anyone wi
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. China Biologic Products Begins Annual Maintenance of its Production Facilities
2. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
3. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
4. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
5. Medimetriks Pharmaceuticals, Inc. Begins Operations
6. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
7. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
8. Thomson Scientific Begins Expansion of Web of Science
9. Ohio Task Force Begins Mission of Creating a New 21st Century Industry
10. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
11. SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 ... GRAPHALLOY® self-lubricating bushings mounted in stainless steel ... self-lubricating properties of GRAPHALLOY with the application and ... Stainless Steel Pillow Blocks work exceptionally well ... corrosive or hostile liquids such as acids, alkalies, ...
(Date:5/23/2013)... -- Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., a ... and therapeutics, announced today that StemCyte has become an ... car driven by James Jakes . ... 2013 season.   StemCyte, Inc. and Rahal Letterman ... umbilical cord blood banking and its educational initiative ,Stars ...
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... May 11 N30 Pharma (N30), a biopharmaceutical company focused on the discovery ... oxide, announced today that it has completed a $10 million financing and ... , Joining the Company,s ... , , ...
... /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc.,(Nasdaq: YONG ), ("Yongye" or the "Company") a ... China , today announced that it will conduct a conference call at ... for the quarter ended March 31,2010 . , ... To participate in the live conference call, ...
... China , May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ... on researching, developing, manufacturing and marketing,biopharmaceutical products, today announced that it will ... on May 16, 2010 ,at 8:00pm (Eastern). , ... Following ...
Cached Biology Technology:Yongye International Announces Conference Call to Discuss First Quarter Fiscal Year 2010 Results 23SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010 2
(Date:5/22/2013)... a novel technique that can detect molecular variants in ... one of the most important, though time-consuming, processes in ... in Nature , post-doctoral researcher David Patterson, Professor ... the Center for Free-Electron Laser Science (CFEL) in Hamburg, ... fields to identify molecular variants apart, and to determine ...
(Date:5/22/2013)... to genetic engineering drastically reduces the time and ... the workhorses of biotechnology, scientists are reporting. Published ... the method paves the way for more rapid ... cleanup and other activities. , Keith Shearwin and ... of the genetic material DNA into a bacterium,s ...
(Date:5/22/2013)... pneumophila bacteria is responsible for legionellosis, an infectious ... infect us, this pathogen has developed a complex method ... our cells, thus avoiding these acting against the infectious ... centre, CIC bioGUNE, in which teams from the National ... National Supercomputation Centre in Barcelona (BSC) have also participated, ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Mechanism discovered which aids Legionella to camouflage itself in the organism 2
... Is Force Multiplier for Shelbyville Police Department, ... International,Inc. (OTC Bulletin Board: BKYI), a leader ... solutions, today announced the,award of a contract ... the Department,s first mobile data system. Using,MobileCop(TM) ...
... Provides Both Shape and Volumetric Evaluation ... 2008 Three dimensional visualization,of the right ventricle provides ... treat patients with tetralogy of,Fallot (TOF), according to a ... Issue 1, 107-113)., TOF is a disease that ...
... sickness that currently affects more than 16 million people, with ... areas of South and Central America. And yet the main ... causes serious side effects. Now, new research just published ... the first time a sensitive method for testing and assessing ...
Cached Biology News:BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 2BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 3Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology 2Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology 3Research identifies first method for testing, assessing drug treatments for Chagas' disease 2Research identifies first method for testing, assessing drug treatments for Chagas' disease 3
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
... Loading Buffer contains a precipitant to ensure that ... tracking dye to allow the user to follow ... ReddyRun™: ABgene ® s proprietary mixture ... same buffer composition used in ReddyRun™ molecular weight ...
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
... This CLS number is ... created to easily match ... showing no availability yet, ... old Sigma-Aldrich number (Z71,381-3) ...
Biology Products: